Ravi Kanth Velagapudi

Ravi Kanth Velagapudi

Auto-generated profile, based on publicly available information

Ravi Kanth Velagapudi

Michigan State University College of Human Medicine, Pulmonary and Critical Care Medicine, East Lansing, Michigan, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2022 in Journal of Bronchology & Interventional Pulmonology
Verified
Journal Article
Open access
GCGustavo Cumbo-Nacheli
Gustavo Cumbo-Nacheli
RVRavi K. Velagapudi
Ravi K. Velagapudi
MEMark Enter
Mark Enter
JEJohn P. Iii Egan
John P. Iii Egan
DCDiego Conci
Diego Conci

22 October 2025 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
RAReshma Amin
Reshma Amin
AAAmit Agarwal
Amit Agarwal
JCJackie Chiang
Jackie Chiang
JCJoseph M. Collaco
Joseph M. Collaco
ACA. Ioana Cristea
A. Ioana Cristea
CBChristopher D. Baker
Christopher D. Baker
The increase in tracheostomies among infants and children, driven by medical advances and evolving family preferences, underscores the need for standardized, evidence-based guidelines. This guideline outlines management recommendations for these medically complex and resource-intensive children with tracheostomies, incorporating best evidence on diagnostic tools and streamlined care protocols. This Clinical Practice Guideline adheres to American Thoracic Society policies and procedures, utilizing the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to form clinical questions, summarize evidence, and develop recommendations with a health equity perspective. A multidisciplinary panel with expertise in pediatric tracheostomy care contributed to recommendations for ethical considerations, discharge processes, in-home caregiver requirements, and diagnostic tools (tracheal aspirate cultures, bronchoscopy, and polysomnography). The panel recommends applying ethical principles to guide shared decision-making about tracheostomy placement (strong recommendation). We also recommend a standardized discharge process involving comprehensive family caregiver training for safe transitions from hospital-to-home (conditional recommendation). A continuously awake, trained caregiver to manage emergencies is also recommended for high-risk patients (strong recommendation). The panel recommends tracheal aspirate cultures during acute respiratory episodes to guide antibiotic therapy, but not for routine surveillance (conditional recommendation), bronchoscopy for thorough airway examination before tracheostomy decannulation (strong recommendation), and polysomnography before decannulation to ensure respiratory stability (conditional recommendation). These guidelines aim to standardize and improve the management of pediatric patients with tracheostomies by providing evidence-based recommendations for ethical considerations, discharge planning, and diagnostic assessments. Implementing these guidelines aims to enhance patient safety and quality of life through a structured and patient-centered approach.

9 February 2021 in Current Pulmonology Reports
Verified
Journal Article
Open access
PDF file
RVRavi Kanth Velagapudi
Ravi Kanth Velagapudi
JEJohn P. Egan
John P. Egan
Purpose of Review: The goal of this review is to provide a comprehensive understanding of the pathophysiology, clinical presentation, diagnostic workup, and clinical management of thoracic endometriosis (TE), as well as highlight our personal experience with TE workup and management. Recent Findings: TE can present in a wide range of clinical manifestations. Without high clinical suspicion, diagnosis can be delayed. Since no specific laboratory testing is available, diagnosis is often based on careful history taking, imaging, and direct visualization of endometrial lesions through video-assisted thoracoscopic surgery (VATS). Medical thoracoscopy (MT) may also be a useful tool in the diagnostic workup of TE. Summary: The diagnosis and management of TE require a multidisciplinary approach and a high index of clinical suspicion. While VATS remains the gold standard for diagnosis, we share our experience using MT to diagnose and manage a case of TE-related hemothorax.

17 July 2018 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
SBSunil Badami
Sunil Badami
SUSunil Upadhaya
Sunil Upadhaya
RVRavi Kanth Velagapudi
Ravi Kanth Velagapudi
PMPushyami Mikkilineni
Pushyami Mikkilineni
RKRanju Kunwor
Ranju Kunwor
GBGhassan Bachuwa
Ghassan Bachuwa
Background. We performed meta-analysis to gather more evidence regarding clinical-molecular subgroups associated with better overall survival (OS) in advanced melanoma treated with checkpoint inhibitors. Materials and Methods. We performed a systematic search of PubMed, Scopus, Cochrane Library, and clinical trial.gov. Randomized clinical trials that compared a checkpoint inhibitor (nivolumab or pembrolizumab) with investigator choice chemotherapy or ipilimumab were included in our study. Hazard ratios (HR) and confidence interval (CI) were calculated for progression-free survival (PFS) and OS for each subgroup using generic inverse model along with the random effect method. Results. A total of 6 clinical trials were eligible for the meta-analysis. OS was prolonged in wild BRAF subgroup (HR 0.65, 95% CI 0.49-0.85, p 0.002), Programmed cell death subgroup (PD-1+) (HR 0.57, 95% CI 0.41-0.80, p 0.001), and high lactate dehydrogenase (LDH) level subgroup (HR 0.60, 95% CI 0.38-0.95, p 0.03). Similarly, we found increased OS in eastern cooperative oncology group (ECOG) 1, males and age >65 years subgroups. Conclusions. Checkpoint inhibitors significantly increased OS in patients with wild BRAF, positive PD-1, and high LDH. However, results should be interpreted keeping in mind associated significant heterogeneity. The results of this study should help in designing future clinical trials.